| | T. Rowe Price Capital Appreciation | PRWCX | 38.50 | +0.16% | 35.47B | 20/11 | |
| | T. Rowe Price Blue Chip Growth | TRBCX | 200.64 | -0.17% | 32.5B | 20/11 | |
| | T. Rowe Price Capital Appreciation I | TRAIX | 38.53 | +0.16% | 29.29B | 20/11 | |
| | T. Rowe Price Blue Chip Growth I | TBCIX | 201.95 | -0.17% | 29.79B | 20/11 | |
| | T. Rowe Price Instl Large Cap Growth | TRLGX | 86.14 | +0.06% | 22.63B | 20/11 | |
| | T. Rowe Price Growth Stock I | PRUFX | 111.55 | +0.04% | 15.83B | 20/11 | |
| | T. Rowe Price Dividend Growth | PRDGX | 81.89 | +0.13% | 13.01B | 20/11 | |
| | T. Rowe Price Mid-Cap Growth I | RPTIX | 111.11 | +0.78% | 13.26B | 20/11 | |
| | T. Rowe Price Growth Stock | PRGFX | 111.09 | +0.04% | 12.72B | 20/11 | |
| | T. Rowe Price Mid-Cap Growth | RPMGX | 110.76 | +0.79% | 12.3B | 20/11 | |
| | T. Rowe Price Dividend Growth I | PDGIX | 81.86 | +0.13% | 11.36B | 20/11 | |
| | T. Rowe Price Equity Index 500 I | PRUIX | 155.89 | +0.01% | 10.79B | 20/11 | |
| | T. Rowe Price New Horizons I | PRJIX | 61.44 | +1.14% | 10.55B | 20/11 | |
| | T. Rowe Price Health Sciences | PRHSX | 93.76 | +1.34% | 8.46B | 20/11 | |
| | T. Rowe Price Equity Income | PRFDX | 38.78 | +0.10% | 8.48B | 20/11 | |
| | T. Rowe Price Equity Income I | REIPX | 38.75 | +0.13% | 8.6B | 20/11 | |
| | T. Rowe Price New Horizons | PRNHX | 61.02 | +1.14% | 8.45B | 20/11 | |
| | T. Rowe Price New America Growth | PRWAX | 80.87 | +0.29% | 8.42B | 20/11 | |
| | T. Rowe Price Equity Index 500 | PREIX | 155.86 | +0.01% | 8.26B | 20/11 | |
| | T. Rowe Price Capital Opportunity | PRCOX | 58.93 | +0.03% | 6.85B | 20/11 | |
